Legend Biotech (LEGN) Interest Expenses (2019 - 2025)

Legend Biotech has reported Interest Expenses for 7 years, with the latest figure at -$5.5 million in Q4 2025.

• For the quarter ending Q4 2025, Interest Expenses fell 5.77% year-over-year to -$5.5 million; the trailing twelve-month figure through Dec 2025 stood at -$11.3 million (down 5.45% YoY), and the FY2025 full-year result was -$21.4 million, up 0.93% from the prior year.
• Interest Expenses for Q4 2025 stood at -$5.5 million, up from -$5.6 million in the prior quarter.
• The five-year high for Interest Expenses was $5.5 million in Q1 2024, with the low at -$5.7 million in Q3 2023.
• Historically, Interest Expenses has averaged -$2.5 million across 5 years, with a median of -$4.1 million in 2022.
• Annual changes were most pronounced in 2022 — Interest Expenses tumbled 2747268.42% — and 2024, when it soared 207.08%.
• Legend Biotech's Interest Expenses stood at -$602000.0 in 2021, then tumbled by 707.48% to -$4.9 million in 2022, then surged by 99.88% to -$5820.0 in 2023, then sank by 89247.08% to -$5.2 million in 2024, then retreated by 5.77% to -$5.5 million in 2025.
• The last three Interest Expenses figures came in at -$5.5 million (Q4 2025), -$5.6 million (Q3 2025), and -$5.2 million (Q2 2025), per Business Quant data.